Literature DB >> 7605995

Cytokine loops involving interferon-gamma and IP-10, a cytokine chemotactic for CD4+ lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma?

A H Sarris1, T Esgleyes-Ribot, M Crow, H E Broxmeyer, N Karasavvas, W Pugh, D Grossman, A Deisseroth, M Duvic.   

Abstract

Human interferon-gamma (IFN-gamma)-inducible protein 10 (IP-10), a C-X-C chemokine, is secreted by IFN-gamma-stimulated keratinocytes and is chemotactic for CD4+ lymphocytes. We therefore investigated its role in the epidermotropism of cutaneous T-cell lymphoma (CTCL) that is known to express IFN-gamma mRNA in the epidermis and is characterized by an indolent course with multiple relapses that remain confined to the skin for many years. By injecting purified recombinant (r) IP-10 we generated a polyclonal rabbit antiserum that specifically recognized and neutralized rIP-10. With immunoperoxidase staining, IP-10 expression was limited to the basal epidermal keratinocytes of normal skin. In biopsies of CTCL lesions the expression of IP-10 was markedly increased and it extended to the suprabasal keratinocytes in 17 of 18 patients, but it was detectable only faintly in the dermal or epidermal lymphoid infiltrates in 2 of these 18 patients. In 1 patient who had matching biopsies performed before and after treatment, IP-10 was overexpressed before treatment, but was normally expressed in the posttreatment biopsy that showed resolution of the CTCL. Increased IP-10 expression was not detected in any of 4 patients with B-cell lymphoma involving the dermis. On the basis of these findings and a review of the literature, we propose that secretion of IFN-gamma by the lymphoid infiltrate in CTCL induces the epidermal keratinocytes to secrete IP-10 that, in turn, is chemotactic for CTCL, accounting for its epidermotropism. This model may be used as a basis for future investigations of the pathogenesis of CTCL.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7605995

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  Sézary T-cell activating factor is a Chlamydia pneumoniae-associated protein.

Authors:  J T Abrams; E C Vonderheid; S Kolbe; D M Appelt; E J Arking; B J Balin
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

2.  A mouse model for the Sézary syndrome.

Authors:  Udo Doebbeling
Journal:  J Exp Clin Cancer Res       Date:  2010-02-11

3.  Maternal serum concentrations of the chemokine CXCL10/IP-10 are elevated in acute pyelonephritis during pregnancy.

Authors:  Francesca Gotsch; Roberto Romero; Jimmy Espinoza; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Offer Erez; Nandor Gabor Than; Samuel Edwin; Moshe Mazor; Bo Hyan Yoon; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2007-10

4.  Dysregulated synthesis of intracellular type 1 and type 2 cytokines by T cells of patients with cutaneous T-cell lymphoma.

Authors:  B N Lee; M Duvic; C K Tang; C Bueso-Ramos; Z Estrov; J M Reuben
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

5.  CXCL10/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia?

Authors:  Francesca Gotsch; Roberto Romero; Lara Friel; Juan Pedro Kusanovic; Jimmy Espinoza; Offer Erez; Nandor Gabor Than; Pooja Mittal; Samuel Edwin; Bo Hyun Yoon; Chong Jai Kim; Shali Mazaki-Tovi; Tinnakorn Chaiworapongsa; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2007-11

6.  Activity of Antimicrobial Peptides and Conventional Antibiotics against Superantigen Positive Staphylococcus aureus Isolated from the Patients with Neoplastic and Inflammatory Erythrodermia.

Authors:  Wioletta Baranska-Rybak; Oscar Cirioni; Malgorzata Dawgul; Malgorzata Sokolowska-Wojdylo; Lukasz Naumiuk; Aneta Szczerkowska-Dobosz; Roman Nowicki; Jadwiga Roszkiewicz; Wojciech Kamysz
Journal:  Chemother Res Pract       Date:  2011-05-12

7.  The response of VEGF-stimulated endothelial cells to angiostatic molecules is substrate-dependent.

Authors:  Christina L Addison; Jacques E Nör; Huijun Zhao; Stephanie A Linn; Peter J Polverini; Christie E Delaney
Journal:  BMC Cell Biol       Date:  2005-10-31       Impact factor: 4.241

8.  Microarray analysis identifies a set of CXCR3 and CCR2 ligand chemokines as early IFNbeta-responsive genes in peripheral blood lymphocytes in vitro: an implication for IFNbeta-related adverse effects in multiple sclerosis.

Authors:  Jun-ichi Satoh; Yusuke Nanri; Hiroko Tabunoki; Takashi Yamamura
Journal:  BMC Neurol       Date:  2006-05-19       Impact factor: 2.474

9.  Mycosis fungoides: is it a Borrelia burgdorferi-associated disease?

Authors:  S Miertusova Tothova; S Bonin; G Trevisan; G Stanta
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

10.  Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3.

Authors:  K E Cole; C A Strick; T J Paradis; K T Ogborne; M Loetscher; R P Gladue; W Lin; J G Boyd; B Moser; D E Wood; B G Sahagan; K Neote
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.